OTC/SmallCap IRW

Big Tree Cloud Holdings Limited Announces Implementation of Class A/B Share Structure and 1-for-20 Share Consolidation

SHENZHEN, China, Feb. 19, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company") (NASDAQ: DSY) today announced that it held an extraordinary general meeting onJanuary 30, 2026, at which the shareholders approved the consolidation of every 20 ordinary shares into one ordinary share a...

2026-02-19 21:30 12307

Marvion Inc. Announces Two New Investors, Further Strengthening Capital Base and Advancing Strategic Growth

HONG KONG, Feb. 17, 2026 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) (the "Company" or "Marvion") today announced that onFebruary 2, 2026, the Company entered into Stock Purchase Agreements with two new investors. The transactions were duly disclosed through a Form 8-K filing in accordance with ap...

2026-02-17 21:18 11772

NATURE'S MIRACLE HOLDING INC. PARTICIPATES IN INDOOR AG-CON 2026

ONTARIO, Calif., Feb. 11, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle," "NMHI," or the "Company") (OTCQB: NMHI), a provider of equipment and services for the controlled environment agriculture ("CEA") industry, today announced its participation in Indoor Ag-Con 2026, tak...

2026-02-11 21:30 7979

Locksley Resources' Underground Mapping Reveals Major New Target Boosting High-Grade Antimony Potential at its Mojave Project Desert Antimony Mine

SAN BERNARDINO, Calif., Feb. 10, 2026 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQX: LKYRF/ADR: LKYLY) announced a major new target zone revealed by underground mapping at its Desert Antimony Mine (DAM), part of the company's Mojave Project. This notable finding, the Beefeater Shea...

2026-02-10 23:53 9675

LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders

BEIJING, Feb. 6, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics fo...

2026-02-06 20:00 10821

Cloopen Announces Changes to Board of Directors and Committee Membership

BEIJING, Feb. 5, 2026 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that its Board of Directors (the "Board") has approved resolutions regarding changes to the composition of the Board and the Compensation Committee, effectiveFebruary 5, 2...

2026-02-05 20:00 8932

Goldenstone Acquisition Limited (Ticker: GDST) Announces Intent to Merge with ESG Packaging Innovator Deluxe Technology Group, Targeting 2026 NASDAQ Listing

NEW YORK, TAIPEI, and TOKYO, Feb. 4, 2026 /PRNewswire/ -- Goldenstone Acquisition Limited (Ticker: GDST) ("Goldenstone"), a special purpose acquisition company listed in the U.S. capital market,recently announced the execution of a letter of intent (LOI) for a proposed business combination with ...

2026-02-04 22:00 7615

Nature's Miracle Holding Inc. Appoints Dr. Jinlong "Frank" Du as President of Agricultural Business

ONTARIO, Calif., Feb. 4, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB: NMHI) today announced the appointment ofDr. Jinlong "Frank" Du as President of the Company's Agricultural Business. Dr. Du is a globally recognized entrepreneur and technology leader in indoor growing and contr...

2026-02-04 21:30 8726

CIMG Inc. announced the signing of computing power equipment sales contracts totaling approximately $2 million

HONG KONG, Feb. 3, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance its business partners' sales growth and commercial value, today announced...

2026-02-03 22:20 8228

Locksley Announces High-Grade Antimony Results from Batch Sampling Program at its Mojave Project

SAN BERNARDINO, Calif., Feb. 3, 2026 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQX: LKYRF; OTCQX ADR: LKYLY) announced that a batch sampling program at the DAM antimony (Sb) deposit, part of the Mojave Project in California,  returned high grade antimony results. The batch sampling...

2026-02-03 21:42 7596

FiEE, Inc. Provides Select Preliminary Fourth Quarter and Full-Year 2025 Financial Results and Business Update

Strong revenue growth supported by growing customer base and SaaS Solution Business Expected to achieve a positive Net Income highlighting a successful transformation HONG KONG, Feb. 2, 2026 /PRNewswire/ -- FiEE, Inc. (NASDAQ:FIEE) ("FiEE," the "Company," "we," "our," or similar terms), a tech...

2026-02-03 05:15 9998

CreateAI Debuts First Gameplay Trailer for Heroes of Jin Yong, Positioning Wuxia for a Global Audience

SAN DIEGO and BEIJING, Feb. 1, 2026 /PRNewswire/ -- CreateAI (OTC: TSPH) today released the first gameplay trailer forHeroes of Jin Yong, an upcoming 3A open-world role-playing game based on the legendary works ofJin Yong. Featuring real in-game footage, the trailer offers an early look at the ti...

2026-02-01 22:00 11527

Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)

Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression SYDNEY, Jan. 30, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, to...

2026-01-30 21:00 10216

Tantech Holdings Subsidiary, Tanhome Group Inc., Receives Notice of Allowance from USPTO for "TANHOME" Trademark, Fortifying North American Green Building Strategy

LISHUI, China, Jan. 30, 2026 /PRNewswire/ -- Tantech Holdings Ltd. (Nasdaq: TANH) ("Tantech" or the "Company"), today announced that its U.S. subsidiary, Tanhome Group Inc., has received a Notice of Allowance (NOA) from the United States Patent and Trademark Office (USPTO) related to its applicat...

2026-01-30 18:30 10654

Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer

SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV), metastatic triple-negative breast cancer (TNBC)....

2026-01-27 21:00 9266

Jin Medical International Ltd. To Host Management Fireside Chat

CHANGZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment inChina, announced today that its Chief Executive Officer, tog...

2026-01-26 21:57 19924

LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders

BEIJING, Jan. 20, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics f...

2026-01-20 20:00 8467

Marvion Inc. Enters $200,000 Stock Purchase Agreement to Strengthen Capital Base and Support Strategic Growth

HONG KONG, Jan. 19, 2026 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) (the "Company" or "Marvion") announced today that it has entered into a stock purchase agreement with third-party investorRay Mak Pak Fai (the "Investor"). Under the agreement, the Investor agreed to purchase$200,000 worth of Mar...

2026-01-19 21:18 9450

Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End

SYDNEY, Jan. 8, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA) today announced that its Chief Executive Officer,John Friend, MD, will be in San Francisco next week to participate in meetings during the annual J.P. Morgan Healthcare Conference week (JPM Week). During the week, Kazia will ...

2026-01-08 22:00 3334

Cloopen Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

BEIJING, Jan. 8, 2026 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that the special committee (the "Special Committee") of the Company's board of directors (the "Board"), which was formed to evaluate and consider the previously announced ...

2026-01-08 20:00 4105
123456 ... 40